Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

Posts tagged ‘ESMO 2014 News’

Madrid – we’re here in Spain for the 2014 Congress of the European Society for Medical Oncology (ESMO). It’s proven to be a challenging and frustrating meeting on multiple levels so far, but hopefully it will redeem itself over the weekend as new data that changes the standard of care for cancer patients is presented.

At the end of the day it’s all about the data and making a difference to the lives of cancer patients.

The highlight of the meeting so far was yesterday’s Roche media briefing and the presentation by Dan Chen MD PhD on how the company is making advances in immunotherapy. We’ll be writing up the data he mentioned as it’s presented at the Congress. The quote he showed from Ira Mellman, PhD about the promise of Immunotherapy is one that resonates with us:

Roche Promise of Immunotherapy Quote

At prior ECCO/ESMO’s we’ve written about the industry satellite symposia that take place, many of which feature world-class experts talking about new drugs in development or the treatment landscape. It’s a big disappointment to be excluded from these events for the first time at #ESMO14, especially as many are educational in content or even organized by Continuing Medical Education (CME) companies.

That said, by dint of the fact ESMO can accept data several months after the ASCO abstracts have closed there is new data to talk about at this meeting and we have a very full schedule of sessions to attend today at the Congress.

If you would like to read more about which sessions we’ll be in and our initial impressions of data during the day, do sign-in if you’re a subscriber or sign up to keep abreast as the data rolls out.

4 Comments

The 2014 European Society for Medical Oncology (ESMO) Congress starts this weekend in Madrid, and it finally feels like it is starting to take off with the release today at lunch-time in Europe of the oral abstracts (with the exception of late breakers) to be presented at the meeting.

This blog post is a preview of some of the oral abstracts that caught my attention in a quick preview this afternoon while in Paris en-route to Madrid.

Air France Concorde CDGFollowing its success at ASCO (one subscriber told us it helped him schedule which sessions to attend, another that it enabled him to question his team on what was really hot at the meeting), we’ll be writing a daily blog on Saturday, Sunday and Monday from ESMO.

It’s going to be a live blog in the sense that we plan to regularly update it during the day, and it will include details of which sessions we are in and our initial impressions of data that catches our interest.

More in-depth posts will follow later.

Back to the oral abstracts, subscribers can login below to read about some of the abstracts that have caught my attention. If you are not yet a subscriber, we do hope you will consider joining what is an exclusive club.

If you can only afford to sign up for a quarter you’re in for a treat as in addition to ESMO we will be covering in person two other major medical meetings this fall, including ASH in San Francisco, and (for now) you still get to read all our previous coverage!!

PS: we’ve not mentioned the companies and products covered in this introduction, as that would make it too easy for non-subscribers, or those in the media who constantly ask us at conferences for story ideas… we all need an edge 🙂

The 2014 Congress of the European Society for Medical Oncology (ESMO) will take place in Madrid from September 26 to 30th, and it’s exciting to see details of the meeting start to emerge.

The theme this year is “Precision Medicine in Cancer Care.”

ESMO 2014 Congress Madrid

This conference is the European equivalent of the ASCO annual meeting in Chicago and alternates annually between ESMO and the European CanCer Organization (ECCO) in terms of hosting and organisation.

ESMO Tweets

The Twitter hashtag this year is #ESMO14, one that’s easy to remember, instantly recognizable and short to use!

Do follow @myESMO for latest Congress news if you are not already doing so. A searchable program is now available online. Link to ESMO 2014 Congress Program.

ESMO has already highlighted some presentations and sessions of interest to the media, but we will be waiting until the abstracts to make our own independent selection and reviews will follow on these.

One of the advantages of the ESMO meeting is the August 20th late-breaking abstract deadline.

Given the ASCO deadline is early in the year, this means the meeting has the opportunity for some exciting late-breaking data to be presented. I’m hoping we will see some exciting new immuno-oncology data as the field is moving forward rapidly

Abstract Publication Dates 

In terms of dates for your diary when abstracts will be publicly available online:

Wed Sept 17: Poster Discussion and Posters

Wed Sept 24: Proffered Papers (oral presentations)

Late-breaking abstracts: beginning of session when they will be presented

Abstracts in Press Conference: at end of press conf or beginning of session in which they are presented, whichever comes first.

I think it’s right that late-breaking scientific data should not be made public until the same time as it’s presented at the Congress.

ESMO 2014 Live Blog

After it’s success at ASCO, we’ll be publishing a live blog for subscribers on the Saturday, Sunday and Monday of the Congress. You can find our coverage on the dedicated ESMO14 blog page.

ESMO 2014 already looks like it will be an exciting and interesting Congress. If any subscribers have plans to be in Madrid do let us know. We look forward to saying “hello” over a glass of jerez or two….

error: Content is protected !!